Cannabis ETFs Rally on Trump Rescheduling Expectations

Cannabis exchange-traded funds are experiencing their strongest rally in months as investors position for accelerated federal marijuana rescheduling under the incoming Trump administration. The AdvisorShares Pure US Cannabis ETF (MSOS) and ETFMG Alternative Harvest ETF (MJ) have both posted double-digit gains over the past two weeks, with institutional money flowing back into a sector that has been largely abandoned by mainstream investors since 2021.

The market's optimism centers on Trump's campaign promise to support rescheduling marijuana from Schedule I to Schedule III, a move that would unlock significant tax benefits for US cannabis operators currently barred from standard business deductions under 280E. This regulatory shift could immediately boost profit margins by 20-30% for major multi-state operators, making their valuations more attractive compared to the steep discounts they trade at relative to traditional consumer goods companies.

ETF performance reflects a broader sector rotation as investors differentiate between US and Canadian cannabis plays. MSOS, which focuses exclusively on US operators, has outperformed MJ's more diversified approach that includes struggling Canadian licensed producers like Canopy Growth and Tilray. This divergence highlights how rescheduling benefits would primarily flow to US companies operating in state-legal markets, while doing little for Canadian firms facing oversupply and margin compression.

The timing coincides with improving fundamentals across major US markets, particularly in mature states like California and Colorado where operators have achieved sustainable profitability despite punitive federal tax treatment. Florida's recent ballot measure on adult-use legalization, though ultimately unsuccessful, demonstrated continued voter support for cannabis reform and highlighted the potential for expanded market access under a more favorable federal framework.

Investor enthusiasm remains tempered by execution risk and the complex legislative process required for rescheduling. The DEA maintains final authority over scheduling decisions, and implementation could face delays even with presidential support. However, the ETF rally signals that institutional investors view the regulatory risk-reward profile as increasingly favorable, particularly for established operators with strong cash generation and multi-state footprints positioned to benefit from federal tax reform.